Department of Cardiac Sciences, Libin Cardiovascular Institute, Foothills Medical Center, University of Calgary, Alberta, Canada.
Heart Lung Circ. 2014 Mar;23(3):e100-4. doi: 10.1016/j.hlc.2013.10.098. Epub 2013 Nov 15.
Impella LP 5.0 (Abiomed) is a relatively new technology that has been used over the last few years as a ventricular assist device to provide full circulatory support for patients presenting with cardiogenic shock. There is limited evidence available in literature with regard to insertion approaches, safety, complications and long-term clinical outcomes. Complications that have been reported are device malfunction, pump displacement, intravascular haemolysis, intra-ventricular thrombosis, functional mitral stenosis due to displacement and local vascular complications at vascular access site. We report here the first case with acute mitral regurgitation due to chordal rupture and flail mitral valve leaflet as a result of Impella device displacement, a new complication. Review of literature is also reported.
Impella LP 5.0(雅培)是一种相对较新的技术,在过去几年中被用作心室辅助装置,为出现心源性休克的患者提供全面循环支持。目前,关于插入方法、安全性、并发症和长期临床结果的文献证据有限。已经报道的并发症包括设备故障、泵移位、血管内溶血、心室内血栓形成、因移位导致的功能性二尖瓣狭窄以及血管入路部位的局部血管并发症。我们在此报告首例因 Impella 设备移位导致的腱索断裂和二尖瓣瓣叶连枷样运动引起的急性二尖瓣反流的病例,这是一种新的并发症。同时也对文献进行了回顾。